Anastasia Bougea

Dr. Anastasia Bougea

National and Kapodistrian University of Athens, Athens, Attikí, Greece
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CACostas Anastasiou
Costas Anastasiou
MYMary Yannakoulia
Mary Yannakoulia
MKMary Kosmidis
Mary Kosmidis
Dardiotis EfthimiosDardiotis Efthimios
Dardiotis Efthimios
GHGiorgos M. Hadjigeorgiou
Giorgos M. Hadjigeorgiou
NSNikolaos Scarmeas
Nikolaos Scarmeas
The Mediterranean dietary pattern has been associated with a decreased risk of many degenerative diseases and cognitive function in particular; however, relevant information from Mediterranean regions, where the prototype Mediterranean diet is typically adhered to, have been very limited. Additionally, predefined Mediterranean diet (MeDi) scores with use of a priori cut-offs have been used very rarely, limiting comparisons between different populations and thus external validity of the associations. Finally, associations between individual components of MeDi (i.e., food groups, macronutrients) and particular aspects of cognitive performance have rarely been explored. We evaluated the association of adherence to an a priori defined Mediterranean dietary pattern and its components with dementia and specific aspects of cognitive function in a representative population cohort in Greece. Participants from the Hellenic Longitudinal Investigation of Ageing and Diet (HELIAD), an on-going population-based study, exploring potential associations between diet and cognitive performance in a representative sample from Greek regions, were included in this analysis. Diagnosis of dementia was made by a full clinical and neuropsychological evaluation, while cognitive performance was assessed according to five cognitive domains (memory, language, attention-speed, executive functioning, visuospatial perception) and a composite cognitive score. Adherence to MeDi was evaluated by an a priori score (range 0–55), derived from a detailed food frequency questionnaire. Among 1,865 individuals (mean age 73±6 years, 41% male), 90 were diagnosed with dementia and 223 with mild cognitive impairment. Each unit increase in the Mediterranean dietary score (MedDietScore) was associated with a 10% decrease in the odds for dementia. Adherence to the MeDi was also associated with better performance in memory, language, visuospatial perception and the composite cognitive score; the associations were strongest for memory. Fish consumption was negatively associated with dementia and cognitive performance positively associated with non-refined cereal consumption. Our results suggest that adherence to the MeDi is associated with better cognitive performance and lower dementia rates in Greek elders. Thus, the MeDi in its a priori constructed prototype form may have cognitive benefits in traditional Mediterranean populations.

22 February 2021 in Movement Disorders
Verified
Journal Article
Open access
PDF file
HLHui Liu
Hui Liu
CKChristos Koros
Christos Koros
TSTimo Strohäker
Timo Strohäker
CSClaudia Schulte
Claudia Schulte
MBMaria Bozi
Maria Bozi
TGThomas Gasser
Thomas Gasser
Background: The SNCA gene encoding α‐synuclein (αSyn) is the first gene identified to cause autosomal‐dominant Parkinsonʼs disease (PD).Objective: We report the identification of a novel heterozygous A30G mutation of the SNCA gene in familial PD and describe clinical features of affected patients, genetic findings, and functional consequences.Methods: Whole exome sequencing was performed in the discovery family proband. Restriction digestion with Bbvl was used to screen SNCA A30G in two validation cohorts. The Greek cohort included 177 familial PD probands, 109 sporadic PD cases, and 377 neurologically healthy controls. The German cohort included 136 familial PD probands, 380 sporadic PD cases, and 116 neurologically healthy controls. We also conducted haplotype analysis using 13 common single nucleotide variants around A30G to determine the possibility of a founder effect for A30G. We then used biophysical methods to characterize A30G αSyn.Results: We identified a novel SNCA A30G (GRCh37, Chr4:90756730, c.89 C>G) mutation that co‐segregated with the disease in five affected individuals of three Greek families and was absent from controls. A founder effect was strongly suggested by haplotype analysis. The A30G mutation had a local effect on the intrinsically disordered structure of αSyn, slightly perturbed membrane binding, and promoted fibril formation.Conclusion: Based on the identification of A30G co‐segregating with the disease in three families, the absence of the mutation in controls and population databases, and the observed functional effects, we propose SNCA A30G as a novel causative mutation for familial PD. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society

1 November 2017 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
VCVasilios C Constantinides
Vasilios C Constantinides
GPGeorge P. Paraskevas
George P. Paraskevas
EEEvangelia Emmanouilidou
Evangelia Emmanouilidou
OPOlga Petropoulou
Olga Petropoulou
Anastasia BougeaAnastasia Bougea
Anastasia Bougea
EKElisabeth Kapaki
Elisabeth Kapaki

4 February 2019 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
Anastasia BougeaAnastasia Bougea
Anastasia Bougea
LSLeonidas Stefanis
Leonidas Stefanis
GPGeorge P Paraskevas
George P Paraskevas
EEEvangelia Emmanouilidou
Evangelia Emmanouilidou
KVKostas Vekrelis
Kostas Vekrelis
EKElisabeth Kapaki
Elisabeth Kapaki

21 December 2015 in BMC Ear, Nose and Throat Disorders
Verified
Journal Article
Open access
PDF file
NSNikolaos Spantideas
Nikolaos Spantideas
EDEirini Drosou
Eirini Drosou
Anastasia BougeaAnastasia Bougea
Anastasia Bougea
DADimitrios Assimakopoulos
Dimitrios Assimakopoulos
To assess the prevalence of laryngopharyngeal reflux (LPR) in the Greek general population and its risk factors. Questionnaire based epidemiological, adult participants’ survey. The Reflux Symptom Index (RSI) was used for the assessment of LPR prevalence. The RSI questionnaire was completed by 340 (183 male and 157 female) randomly selected subjects. Subjects with RSI score ≥13 were considered as LPR patients and those with RSI score 0.05). The age group of 50–64 years showed the higher prevalence rate. Tobacco smoking and alcohol consumption were found to be related with LPR. No reported concomitant disease or medication was found to be related with LPR. LPR prevalence in the Greek general population was found to be 18.8 %. Tobacco smoking and alcohol consumption were found to be related with LPR.

12 January 2021 in Movement Disorders
Verified
Journal Article
Open access
PDF file
Stylianos RavanidisStylianos Ravanidis
Stylianos Ravanidis
Anastasia BougeaAnastasia Bougea
Anastasia Bougea
DKDimitra Karampatsi
Dimitra Karampatsi
Nikolaos PapagiannakisNikolaos Papagiannakis
Nikolaos Papagiannakis
MMMatina Maniati
Matina Maniati
Epaminondas DoxakisEpaminondas Doxakis
Epaminondas Doxakis
Background: New noninvasive and affordable molecular approaches that will complement current practices and increase the accuracy of Parkinson's disease (PD) diagnosis are urgently needed. Circular RNAs (circRNAs) are stable noncoding RNAs that accumulate with aging in neurons and are increasingly shown to regulate all aspects of neuronal development and function.Objectives: Τhe aims of this study were to identify differentially expressed circRNAs in blood mononuclear cells of patients with idiopathic PD and explore the competing endogenous RNA networks affected.Methods: Eighty‐seven circRNAs were initially selected based on relatively high gene expression in the human brain. More than half of these were readily detectable in blood mononuclear cells using real‐time reverse transcription‐polymerase chain reaction. Comparative expression analysis was then performed in blood mononuclear cells from 60 control subjects and 60 idiopathic subjects with PD.Results: Six circRNAs were significantly down‐regulated in patients with PD. The classifier that best distinguished PD consisted of four circRNAs with an area under the curve of 0.84. Cross‐linking immunoprecipitation‐sequencing data revealed that the RNA‐binding proteins bound by most of the deregulated circRNAs include the neurodegeneration‐associated FUS, TDP43, FMR1, and ATXN2. MicroRNAs predicted to be sequestered by most deregulated circRNAs have the Gene Ontology categories “protein modification” and “transcription factor activity” mostly enriched.Conclusions: This is the first study that identifies specific circRNAs that may serve as diagnostic biomarkers for PD. Because they are highly expressed in the brain and are derived from genes with essential brain functions, they may also hint on the PD pathways affected. © 2021 Biomedical Research Foundation, Academy of Athens. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.